Evidence map›Paper›PMID 35392381›Full record

ArticleFrontiers in psychiatry2022

Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice-Identifying Group Differences and Predictors.

Maximilian Meyer, Patrick Brunner, Leonie Geissmann, Martin Gürtler, Fabienne Schwager, Rowena Waldis, Marc Vogel, Gerhard A Wiesbeck, Kenneth M Dürsteler

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maximilian MeyerClinic for Adult Psychiatry, University Psychiatric Clinics, University of Basel, Basel, Switzerland.
Patrick BrunnerClinic for Adult Psychiatry, University Psychiatric Clinics, University of Basel, Basel, Switzerland.
Leonie GeissmannDivision of Cognitive Neuroscience, Department of Psychology, University of Basel, Basel, Switzerland.
Martin GürtlerHealth Center Allschwil (Gesundheitszentrum Allschwil AG), Allschwil, Switzerland.
Fabienne SchwagerClinic for Adult Psychiatry, University Psychiatric Clinics, University of Basel, Basel, Switzerland.
Rowena WaldisClinic for Adult Psychiatry, University Psychiatric Clinics, University of Basel, Basel, Switzerland.
Marc VogelClinic for Adult Psychiatry, University Psychiatric Clinics, University of Basel, Basel, Switzerland.
Gerhard A WiesbeckDepartment of Clinical Research, University of Basel, Basel, Switzerland.
Kenneth M DürstelerClinic for Adult Psychiatry, University Psychiatric Clinics, University of Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Sexual dysfunctions (SDs) show a marked impact on a person's general wellbeing. Several risk-factors like physical and mental illnesses as well as alcohol and tobacco use have to date been identified to contribute to the occurrence of SDs. The impact of opioid-agonist treatment (OAT) on SDs remains unclear, with some studies demonstrating an improvement after methadone maintenance treatment (MMT) initiation. However, no studies on the prevalence and predictors of SDs in heroin-assisted treatment (HAT) exist to date. Methods: A cross-sectional study was conducted with patients from a MMT center ( Results: Twenty-five percent of the GP sample ( Discussion: Age, depressive state, and opioid dependence predicted the occurrence of SDs in the total sample. It remains unclear whether SDs are caused by opioid intake itself or result from other substance-use related lifestyle factors, that were not controlled for in this study. A lack of help-seeking behavior was observed in our sample, underlining the importance of clinicians proactively inquiring about the sexual health of their patients. Conclusion: The high prevalence of SDs observed in MMT does not differ from the prevalence in HAT. Clinicians should actively inquire about their patients' sexual health in GP and OAT centers alike.

Indexed as

erectile dysfunctionheroin dependenceopioid dependenceopioid use disordersexual dysfunction

Identifiers

PMID35392381
PMCPMC8980546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.